Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 2Endocrine 2

Conditions

Squamous Cell Carcinoma of Head and Neck 272Head and Neck Neoplasms 241Carcinoma, Non-Small-Cell Lung 92Thyroid Neoplasms 85Melanoma 67Mouth Neoplasms 64Oropharyngeal Neoplasms 61Nasopharyngeal Carcinoma 60Breast Neoplasms 51Colorectal Neoplasms 49Ovarian Neoplasms 44Lung Neoplasms 44Neoplasm Metastasis 43Carcinoma, Squamous Cell 39Uterine Cervical Neoplasms 38Neoplasms 37Carcinoma, Renal Cell 33Stomach Neoplasms 31Laryngeal Neoplasms 31Triple Negative Breast Neoplasms 29Carcinoma 28Esophageal Neoplasms 27Endometrial Neoplasms 27Sarcoma 26Pancreatic Neoplasms 26Salivary Gland Neoplasms 24Prostatic Neoplasms 23Hypopharyngeal Neoplasms 22Urinary Bladder Neoplasms 21Thyroid Cancer, Papillary 21

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Differentiated Thyroid Cancer × Head & Neck × 90 days × Clear all
NCT06671184 2026-05-07

Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy

Shanghai 6th People's Hospital

Recruiting
500 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT05852223 2026-04-20

NePenThe

Istituti Clinici Scientifici Maugeri SpA

Phase 2 Recruiting
25 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡